CARUSO JAMES V
SEC insider (Form 3/4/5 filer). CIK 0001202770. President & CEO at Cellectar Biosciences, Inc. (CLRB). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in FLORHAM PARK, NJ.
Companies CARUSO JAMES V has filed insider reports for
- Cellectar Biosciences, Inc. (CLRB): Director, Officer, President & CEO
CARUSO JAMES V
CIK: 0001202770
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cellectar Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 7, 2026CLRB
Cellectar Biosciences, Inc.
AwardDirectStock option (right to buy)
250K shares- - May 7, 2026CLRB
Cellectar Biosciences, Inc.
PurchaseDirect8.7K shares at avg. $2.88$25K - Jul 2, 2025CLRB
Cellectar Biosciences, Inc.
PurchaseDirect10K shares at avg. $4.99$50K - Feb 14, 2025CLRB
Cellectar Biosciences, Inc.
AwardDirectStock option (right to buy)
900K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 | CLRB Cellectar Biosciences, Inc. | Award Stock option (right to buy) | 250,000 | - | - | Direct |
| May 7, 2026 | CLRB Cellectar Biosciences, Inc. | Purchase | 8,680 | $2.88 | $24,998 | Direct |
| Jul 2, 2025 | CLRB Cellectar Biosciences, Inc. | Purchase | 10,000 | $4.99 | $49,900 | Direct |
| Feb 14, 2025 | CLRB Cellectar Biosciences, Inc. | Award Stock option (right to buy) | 900,000 | - | - | Direct |
1-4 of 4 transactions